| Name | 6H-Purin-6-one,9-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-1,9-dihydro |
|---|---|
| Synonyms |
2'-FANA-Inosine
9H-Fluorene,9-(2-cyclopropyl-2-propenylidene) 6H-Purin-6-one,9-(2-deoxy-2-fluoro-β-D-abinofuranosyl)-1,9-dihydro 9-(2-cyclopropyl-2-propenylidene)fluorene 2’-Deoxy-2’-fluoroabino inosine 9-(2-Deoxy-2-fluoro-beta-D-abinofuranosyl)-1,9-dihydro-6H-purin-6-one 9-((2R,3S,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one 2'-Deoxy-2'-fluoroabino inosine 6H-Purin-6-one, 9-(2-deoxy-2-fluoro-β-D-abinofuranosyl)-1,9-dihydro 9-(2-deoxy-2-fluoro-D-abinofuranosyl)hypoxanthin 9-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one 9-(2'-Deoxy-2'-fluoro-β-D-abinofuranosyl)hypoxantine 9-(2-deoxy-2-fluoro-D-abinofuranosyl)hypoxanthine 9-(2-Deoxy-2-fluoro-beta-D-abinofuranosyl)-1,9-dihydro-6H |
| Description | 2’-Deoxy-2’-fluoroarabino inosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 2.01 |
|---|---|
| Boiling Point | 744.8ºC at 760 mmHg |
| Molecular Formula | C10H11FN4O4 |
| Molecular Weight | 270.22 |
| Exact Mass | 270.07600 |
| PSA | 113.26000 |
| Index of Refraction | 1.81 |
|
~%
98983-40-5 |
| Literature: Journal of Organic Chemistry, , vol. 57, # 2 p. 553 - 559 |
|
~%
98983-40-5 |
| Literature: Chemical and Pharmaceutical Bulletin, , vol. 37, # 2 p. 336 - 339 |
|
~%
98983-40-5 |
| Literature: Chemical and Pharmaceutical Bulletin, , vol. 37, # 2 p. 336 - 339 |
|
~%
98983-40-5 |
| Literature: Chemical and Pharmaceutical Bulletin, , vol. 37, # 2 p. 336 - 339 |
|
~%
98983-40-5 |
| Literature: Chemical and Pharmaceutical Bulletin, , vol. 37, # 2 p. 336 - 339 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |